The frequency depends on your B12 levels and medical history
related full-length recombinant thymosin beta-4 (a different formulation than the marketed TB-500 fragment) has also been examined in small human studies for cardiac and dermatologic indications Examined in preclinical models, including diabetic rat Achilles tendon and rat ligament-injury studies, for actin-binding, cell-migration, and angiogenic activity that researchers have proposed as a mechanism for tendon and ligament repair, though this literature remains comparatively sparse for musculoskeletal applications specifically Known risks and side effects: Because TB-500 is manufactured and sold without FDA oversight as a "research chemical," independent testing and industry reporting describe wide variability in purity (with some products measured well below labeled potency) and contamination with heavy metals or bacterial byproducts, unlike pharmaceutical-grade recombinant thymosin beta-4 used in registered clinical trials Thymosin beta-4's core mechanisms, angiogenesis and cell migration, are also pathways exploited by tumors
PRODUCT SPECIFICATIONS: Format: 10 lyophilized vials (consistent lot number for study continuity) Strength: 100mg per vial Storage: -20C, protected from light Reconstitution: Bacteriostatic water (not included) COA: Available for each production batch Intended Use: Research Use Only NOT for human consumption RESEARCH APPLICATIONS: Collagen synthesis pathway studies Tissue regeneration research Anti-inflammatory cascade investigation Wound healing modulation studies Antioxidant mechanism research INSTITUTIONAL VALUE PROPOSITION: Consistent lot number across 10 vials ensures experimental reproducibility Cost-effective bulk pricing for labs running extended study protocols Same-day shipping for time-sensitive research timelines Net-30 payment terms available for qualifying institutions QUALITY ASSURANCE: Synthesized in FDA-registered facilities under cGMP protocols Third-party COA verification (purity, endotoxin levels) Full chain-of-custody documentation for audit compliance REGULATORY NOTICE: This product is manufactured and distributed for research purposes only
Studies have found significant percentages of ergogenic supplements containing incorrect amino acid sequences or exceeding safe endotoxin thresholds
